Invicorp (Phentolamine Mesilate, Aviptadil)

Phentolamine mesilate blocks alpha‑adrenergic receptors, preventing vasoconstriction, while aviptadil, a peptide analog, raises intracellular cAMP levels. Together they relax smooth muscle in the corpus cavernosum, dilate penile arteries, and increase blood inflow to facilitate erection.

The dose of Invicorp is determined by the prescribing clinician based on the patient’s condition, response, and safety considerations. Healthcare professionals calculate the appropriate volume and concentration for each intracavernous injection.

Invicorp is not recommended for use in pregnancy or while breastfeeding because safety data are lacking. The product is intended for adult male patients with erectile dysfunction, and its use in women is contraindicated.

To order Invicorp, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Unlike oral PDE5 inhibitors, Invicorp is an injectable vasodilator that directly relaxes penile smooth muscle, offering rapid onset and an option for patients who do not respond to oral therapy. It provides a mechanical alternative rather than a systemic oral medication.

Invicorp should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the product in its original packaging to maintain sterility and potency until use.

Invicorp is administered by a trained healthcare professional via intracavernous injection directly into the corpus cavernosum of the penis. Proper aseptic technique and dosage calculation are essential for safe and effective use.

The most serious risks include priapism lasting longer than four hours, severe hypotension that can cause dizziness or fainting, and rare allergic reactions such as rash, swelling, or anaphylaxis. Prompt medical attention is required if these events occur.

Invicorp should not be used by patients with known hypersensitivity to phentolamine, aviptadil, or any formulation components, those with uncontrolled hypertension, recent myocardial infarction, or severe cardiovascular disease, and it is contraindicated in women, pregnant or lactating individuals.